NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/04/2025
Back to search
Official data from USPTO
WUXI XDC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WUXI XDC
ST13
US500000097778983Class
40, 42
Filing
97778983
Registration
7674839
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
02/04/2025
Trademark type
Word
Nice classes
40, 42
Filing date
02/02/2023
Registration date
02/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2025
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/30/2021
First use in commerce
05/13/2021
Drawing code
4
Owner type
03
Owner location
Grand Cayman, KY
Examiner
SCHMIDT, JOHN
Law office
N10
Current location
INTENT TO USE SECTION
Holders and representatives
Holders
WuXi XDC Cayman Inc.
Representatives
Eric Lamb FROST BROWN TODD LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of antibody-drug conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates
Class 42
Development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceuticalbiomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/13/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/13/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
07/25/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2023
PUBO
PUBLISHED FOR OPPOSITION
12/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2023
DOCK
ASSIGNED TO EXAMINER
10/31/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/19/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/19/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/19/2023
NWAP
NEW APPLICATION ENTERED
02/07/2023
Continuous trademark protection
Get notified about every new filing that threatens WUXI XDC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.